Hopman Mark sold BBNX
June 2, 2026 · Form 4 insider transaction
Hopman Mark sold 5,329 shares of Beta Bionics, Inc. at $12.61 per share, a transaction worth $67.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
5,329
Price
$12.61
Total value
$67.2K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 2, 2026
Filing dateJune 3, 2026
Shares owned after130,887
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.; The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.